TOPICAL PHARMACEUTICAL FORMULATIONS COMPRISING PIMECROLIMUS, CLOBETASOL AND CALCIPOTRIOL FOR THE TREATMENT OF PSORIASIS

摘要

The present invention relates to a topical pharmaceutical formulation comprising pimecrolimus as calcineurin inhibitor, clobetasol as a corticosteroid, or calcipotriol as a vitamin D derivative, as a calcineurin inhibitor for the treatment of psoriasis, sebopsoriasis or seborrheic dermatitis in humans and other mammals.